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The mechanism conferring resistance to paromomycin in Streptomyces rimosus forma paromomycinus, the
producing organism, was studied at the level of both protein synthesis and drug-inactivating enzymes.
Ribosomes prepared from this organism grown in either production or nonproduction medium were fully
sensitive to paromomycin. A paromomycin acetyltransferase and a paromomycin phosphotransferase, both
characteristic of the producer, were highly purified from extracts prepared from two Streptomyces lividans
transformants harboring the relevant genes inserted in pIJ702-derived plasmids. In vitro, paromomycin was
inactivated by either activity. In vivo, however, S. lividans clones containing the gene for either enzyme inserted
in the low-copy-number plasmid pU41 were resistant to only low levels of paromomycin. In contrast, an S.
lividans transformant containing both genes inserted in the same pLU4l-derived plasmid displayed high levels
of resistance to paromomycin. These results indicate that both genes are required to determine the high levels
of resistance to this drug in the producing organism. Paromomycin is doubly modified by the enzymes.
However, whereas acetylparomomycin was a poorer substrate than paromomycin for the phosphotransferase,
phosphorylparomomycin was modified more actively than was the intact drug by the acetyltransferase. These
findings are discussed in terms of both a permeability barrier to paromomycin and the possible role(s) of the
two enzymes in the biosynthetic pathway of this antibiotic.
The process(es) that confers resistance to aminocyclitol
antibiotics in those actinomycetes that produce them ap-
pears to be complex. Mechanisms for self-protection involve
either enzymatic inactivation of the antibiotics by O-phos-
photransferases (APH) or N-acetyltransferases (AAC) and/
or ribosomal modification (by 16S rRNA methylases) (4, 22).
Study of these systems is facilitated by cloning the genes
determining resistance and expressing them in a drug-sensi-
tive organism such as Streptomyces lividans. Thus, Strepto-
myces hygroscopicus, the producer of hygromycin B, has
been reported to contain a single gene for a hygromycin B
APH (15). In contrast, Streptomyces fradiae, the neomycin
producer, contains two genes for resistance, encoding either
APH or AAC activity (24). Interestingly, S. lividans clones
harboring either activity display only low levels of resistance
to neomycin, although an S. lividans clone carrying both
genes is resistant to high drug concentrations (24). Antibiot-
ic-inactivating enzymes have not been found in Streptomy-
ces tenjimariensis, the producer of istamycin (28, 29). In-
stead, the strain produces a 16S rRNA methylase which
renders ribosomes resistant to this drug (22). Similar results
have been obtained with Micromonospora purpurea, a gen-
tamicin producer (20).
Other actinomycetes present an even more complex pic-
ture. Streptomyces kanamyceticus has both resistant ribo-
somes and AAC activity (16), and Streptomyces tenebrarius
contains resistant ribosomes in addition to AAC and APH
activities (30). The reasons for this multiplicity of mecha-
nisms are not clear, although the development or acquisition
of the genetic determinant(s) for resistance in any arctinomy-
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cete may have been imposed by the chemical composition of
the antibiotic, its mode and site of action, and/or its biosyn-
thetic pathway. The expression of a gene for resistance
caused by a metabolic constraint seems to occur in S.
kanamyceticus, in which resistant ribosomes were found to
be present only in cells grown in a production medium (16).
Streptomyces rimosus forma paromomycinus produces
the aminocyclitol antibiotic paromomycin and contains both
a paromomycin phosphotransferase PPH and a paromomy-
cin AAC (18). The genes encoding these enzymes from S.
rimosus have been cloned in S. lividans (14, 18). In this
work, we examined the biochemical properties of the en-
zymes. We also considered how these genes, either individ-
ually or in concert, are implicated in determining resistance
to paromomycin in S. lividans.
MATERIALS AND METHODS
Bacteria, plasmids, and growth conditions. The paromomy-
cin producer S. rimosus forma paromomycinus NRRL 2455
was provided by D. T. Wicklow (Northern Regional Re-
search Center, Peoria, Ill.). S. lividans 1326, the host for
cloning Streptomyces plasmids, and plasmids pIJ41 (23) and
pIJ702 (10) were provided by D. A. Hopwood (John Innes
Institute, Norwich, England). Plasmid pMJ1.2 (a pIJ702
derivative) encoding the PPH enzyme from S. rimosus, was
described elsewhere (18). Other plasmids were obtained as
indicated in Fig. 1.
S. rimosus was grown in liquid production medium MAS,
which contained (per liter): 20 g of soluble starch (E. Merck
AG, Darmstadt, Federal Republic of Germany), 20 g of
maltose, 10 g of NaNO3, and 30 g of soybean meal. The pH
was adjusted to 7.0. S. lividans was grown on liquid YEME
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medium (8) supplemented with 34% sucrose and 5 mM
MgCl2. Solid medium for Streptomyces spp. was R5 (2).
Resistance to paromomycin was examined in minimal solid
medium (7).
Cloning procedures. Plasmid DNA was prepared as de-
scribed elsewhere (11). DNA recombinant techniques and
transformation of S. lividans were also carried out as de-
scribed elsewhere (23, 26).
Preparation of cell extracts. Cell fractions intended for
poly(U)-directed polyphenylalanine synthesis were obtained
as reported elsewhere (19). To prepare the soluble fraction
(S100) for purification of enzyme activities, mycelia were
collected by centrifugation and washed once with buffer B
(10 mM Tris hydrochloride [pH 7.4], 10 mM MgCl2, 50 mM
NH4Cl, 5 mM 2-mercaptoethanol). Mycelia were broken
with alumina (1.5 to 2 g/g [wet weight] of mycelium) at 4° C,
resuspended in buffer B, and centrifuged at 17,000 x g for 10
min. The resulting supernatant was treated with DNase (5
,ug/ml) and centrifuged at 100,000 x g for 2 h. The superna-
tant (S100 fraction) was used immediately or kept at -70° C.
Enzyme assays. The methods used to assay PPH and AAC
activities were based on the radiochemical assay described
by Haas and Dowding (5). For PPH, reaction mixtures (50
,lI) contained, except as otherwise indicated, 100 mM Tris
hydrochloride (pH 7.4), 300 ,uM [-y-32P]ATP (specific activ-
ity, 300 mCi/mmol), 1 mM MgCI2, 100 ,uM antibiotic, and 10
ng of purified PPH. For AAC, reaction mixtures (50 ,ul)
contained, except as otherwise indicated, 10 mM Tris hy-
drochloride (pH 7.4), 30 mM MgCl2, 200 p.M [1-14C]acetyl
coenzyme A (acetyl-CoA; specific activity, 57 mCi/mmol),
100 p.M antibiotic, and 30 ng of purified AAC. Reactions
took place at 30° C for 20 min (except as otherwise indicated).
Portions (35 ,ul each) were then spotted on phosphocellulose
(P-81; Whatman, Inc., Clifton, N.J.) strips, which were
immediately immersed in tap water, washed several times
with distilled water, and dried. Radioactivity was estimated
in a liquid scintillation spectrometer. One unit of PPH or
AAC activity was defined as the amount of protein catalyz-
ing the modification of 1 nmol of paromomycin per min at
300C.
Inactivation of paromomycin. Inactivation of paromomy-
cin by either phosphorylation or acetylation was determined
by the paper disk method, using Bacillus subtilis as the
sensitive organism (17).
Purification of enzyme activities. PPH activity was purified
by affinity column chromatography essentially as described
earlier (31) except that a 50% ammonium sulfate cut of an
S100 fraction from S. lividans(pMJ1.2) (see Fig. 1) was used
and paromomycin (instead of hygromycin B) was coupled to
epoxy-activated Sepharose 6B. The final resin was stable for
several months at 40C. PPH was eluted with a 2-mg/ml
solution of paromomycin in 10 mM Tris hydrochloride buffer
(pH 7.4), 10 mM MgCl2, 400 mM (NH4)2SO4, and 6 mM
2-mercaptoethanol. Paromomycin was removed from the
enzyme preparation by successive dialysis and a short
incubation with ATP (31). PPH was purified 42-fold.
Purification of AAC activity was also achieved by affinity
column chromatography. The resin was prepared as de-
scribed elsewhere (31) except that epoxy-activated Sepha-
rose 6B (1.25 g) was treated with 40 ml of 0.1 M sodium
carbonate (pH 10.85) containing 20 mg of paromomycin
sulfate per ml. The final resin was stable at 4° C for only a few
weeks. A 40 to 60% ammonium sulfate cut was applied to the
column, and enzyme was eluted by applying a 50- to 500-mM
NaCl gradient made up in buffer B. The active fractions were
concentrated by chromatography through a DEAE-cellulose
column, from which AAC enzyme was eluted with 250 mM
NaCl in buffer B. Finally, AAC activity was purified by
Bio-Gel P-200 (Bio-Rad Laboratories, Richmond, Calif.)
column chromatography. AAC was purified 377-fold.
Protein concentrations were estimated as described else-
where (3). Proteins eluted from columns were detected by
continuous recording of A280.
Determination of enzyme molecular weights. A sample of
each of the purified PPH and AAC activities was combined
with molecular weight marker proteins. The resulting mix-
tures were passed, independently, through a Bio-Gel P-200
column. Enzyme activities and A280 were measured in each
fraction of the eluates.
In addition, molecular weights and purities of the enzyme
preparations were estimated by polyacrylamide gel electro-
phoresis in the presence of sodium dodecyl sulfate as de-
scribed by Laemmli (12).
Determination of kinetic constants. The Km values of PPH
and AAC for the various substrates were determined by
using initial velocities. For PPH, reaction mixtures (50 ,ul)
were made up in 10 mM Tris hydrochloride (pH 7.5)-l mM
MgCl2. The specific activity of [_y-32P]ATP was 300 Ci/mol,
and the substrate concentrations varied from 1 to 12 p.M for
paromomycin (in the presence of 300 p.M ATP) and 25 to 800
p.M for ATP (in the presence of 100 p.M paromomycin).
Reaction mixtures were prewarmed at 30° C, and the assays
were started by adding 17.4 and 104.4 mU of PPH for
paromomycin and ATP, respectively. Incubation was con-
tinued for 4 min.
For AAC, reaction mixtures (50 p.l) were made up in 10
mM Tris hydrochloride (pH 8.5)-30 mM MgCI2. The specific
activity of [1-14C]acetyl-CoA was 57 mCi/mmol, and the
substrate concentrations were varied between 1 and 5 p.M
for paromomycin (in the presence of 200 pM [1-_4C]acetyl-
CoA) and between 10 and 225 p.M for [1-14C]acetyl-CoA (in
the presence of 100 p.M paromomycin). No higher concen-
trations of acetyl-CoA were used because the acetylation
reaction was then inhibited. Reaction mixtures were pre-
warmed at 30° C, and the assays were started by addition of
1.8 and 28.8 U of AAC for paromomycin and acetyl-CoA,
respectively. Incubation was continued for 10 min.
Purification of phosphorylparomomycin. Paromomycin
was phosphorylated with [y-32P]ATP of low specific activity
and purified PPH enzyme. Phosphorylparomomycin was
purified by column chromatography through Amberlite IRC-
50 (Rohm & Haas Co., Philadelphia, Pa.) and preparative
thin-layer chromatography on Silica Gel 60 F254 (Merck). A
sample (100 p.g) of final product had no activity on B. subtilis
as determined by the disk method. Activity was recovered
after treatment of phosphorylparomomycin with alkaline
phosphatase.
RESULTS AND DISCUSSION
Effect of paromomycin on polyphenylalanine synthesis by S.
rimosus ribosomes. Poly(U)-directed polyphenylalanine syn-
thesis by homologous and heterologous combinations of
supernatant and ribosome fractions from S. lividans and S.
rimosus showed that S. rimosus ribosomes were sensitive to
paromomycin (10-p.M drug concentrations giving higher than
90% inhibition). This sensitivity was independent of the
growth conditions, in either YEME or production (MAS)
medium, of S. rimosus. In addition, supernatants from S.
rimosus inactivated paromomycin in the presence of either
ATP or acetyl-CoA as determined by the disk assay against
B. subtilis (results not shown). These data suggest that
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FIG. 1. Restriction maps of Streptomyces plasmids. The restriction map of plasmid pMJ1.2 was taken from Pdrez-Gonzailez and Jimdnez
(18). To prepare pMA1.2, the PstI-SstI DNA fragment, containing pph, from pMJ1.2 was ligated to the PstI-SstI replicon fragment from pIJ41
(22). To prepare pMA2.1, the SphI-SstI DNA fragment, containing pph, from pMJ1.2 was ligated to the SphI-SstI replicon fragment from
pIJ41 (22). To obtain pMJ4.2, plasmid pMJ4 (13) was partially digested with MboI, and the resulting DNA fragments were ligated to
BglII-restricted pIJ702. S. lividans protoplasts were then transformed with the ligation mixture, and transformants were selected in the
presence of paromomycin. One of these transformants contained MJ4.2. To construct pMA4.2, the SstI-PstI DNA fragment, containing
aacC7, from pMJ4.2 was ligated to the SstI-PstI replicon fragment from pIJ41 (22). To prepare pMA4221, the SphI-SstI DNA fragrnent from
pMJ1.2 was ligated to SstI-plus-StuI-restricted pMJ4.2. The overhanging StuI and SphI sites were then filled with Klenow enzyme, followed
by blunt-end ligation. Arrows indicate direction of transcription. Pmel and tsr indicate tyrosinase gene promoter and thiostrepton resistance
gene, respectively.
resistance to paromhomycin in S. rimosus may be mediated
by drug inactivation, with no involvement of the ribosomes.
This would contrast with the situations for S. kanamyceticus
(16) and S. tenebrarius (30), in which both ribosomal resis-
tance and drug-inactivating enzymes have been found.
Purification and biochemical charadterization of PPH and
AAC activities. PPH and AAC were purified from S. lividans
clones harboring plasmid pMJ1.2 (Fig. 1) or pMJ4.2, as
described in Materials and Methods. The final enzyme
preparations were analyzed by polyacrylamide gel electro-
phoresis in sodiutm dodecyl sulfate. PPH showed only one
band, of Mr 33,000, and AAC had a main band of Mr 32,000
contaminated with a faint band of much higher molecular
weight (results not shown). These values are identical to
those obtained for PPH and AAC by gel filtration on a
Bio-Gel P-200 column (results not shown). Therefore, the
two enzyme activities appeared to be highly purified and
accordingly were used to carry out the biochemical studies
described below.
PPH activity was totally dependent on Mg2", with 1 mM
being the optimutn concentration. This value is rather lower
than that (about 10 mM) found for other aminocyclitol
APHs. The AAC enzyme was active in the absence of Mg2+,
although maximum activity was at a 30-mM concentration.
PPH displayed maximum activity at pH 7.5 (Tris hydrochlo-
ride buffer), and AAC had two maxima at pH 6 (citrate-
phosphate buffer) and 8.5 (Tris hydrochloride buffer).
The Km values of PPH for paromomycin and ATP were
4.16 and 70 ,uM, respectively. These values could be accu-
rately measured because the rate of phosphorylation of
paromomycin was linear against time, in contrast to what is
generally found with aminocyclitol APH. The Km values of
AAC for paromomycin and acetyl-CoA were 2.76 and 125
p.M, respectively.
The substrate specificities of PPH and AAC are presented
in Table 1. Paromomycin, neomycin C, ribostamycin, and,
to a lesser extent, neomycin B were good substrates for PPH
activity. In contrast, paromamine and neamine (two-ring
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TABLE 1. Substrate specificities of PPH and AAC activities
Sp act"
Substrate
PPH AAC
Amikacin 0.00 0.00
Butirosin 0.05 0.00
G-418 0.00 0.19
Gentamicin C1 0.01 0.19
Gentamicin Cia 0.01 0.31
Hygromycin B 0.00 0.00
Kanamycin A 0.12 0.53
Kanamycin B 0.15 0.86
Kasugamycin 0.00 0.00
Lividamine 0.08 0.06
Lividomycin A 0.01 0.61
Neamine 0.13 0.05
Neomycin B 0.40 0.57
Neomycin C 0.88 0.54
Netilmicin 0.00 0.54
Paromamine 0.09 0.07
Paromomycin 0.87 0.49
Ribostamycin 0.90 0.08
Sisomicin 0.00 0.54
Spectinomycin 0.00 0.00
Streptomycin 0.00 0.00
Tobramycin 0.01 0.75
" Assays were performed as indicated in Materials and Methods. Data are
expressed as nanomoles of transferred 32p or 14C per nanomole of substrate.
derivatives), lividamine, and kanamycins A and B were poor
substrates. Lividomycin A, a member of the neomycin group
but lacking the 3'-hydroxyl group, and other compounds
listed in Table 1 were not substrates for PPH. These results
are similar to those found with APH enzymes of the 3' type
(25), although, in contrast to these enzymes, PPH did not
actively modify the kanamycins.
AAC clearly modified paromomycin, neomycins B and C,
lividomycin A, kanamycins A and B, gentamicins C1 and
Cia, tobramycin, sisomicin, netilmicin, and G-418. Paroma-
mine, neamine, ribostamycin, and lividomycin A were only
slightly acetylated. Other aminocyclitol antibiotics indicated
in Table 1 were not substrates for AAC. This range of
substrates is characteristic of aminocyclitol 3-N-acetyltrans-
ferase type III [AAC(3)-III] enzymes (25). Therefore, the
activity from S. rimosus may be included in this group of
aminocyclitol acetyltransferase activities. In agreement with
this conclusion is the finding that the amino acid sequence of
AAC, as deduced from the nucleotide sequence of the
corresponding gene, has strong similarities to that of two
other AAC(3)-III and -IV enzymes (14). Two additional
AAC(3) activities have been described, one in Micromono-
spora inoyoensis (21) and the other in S. griseus (9). There-
fore, we suggest that AAC(3)-VII provides the AAC activity
of S. rimosus. In the presence of acetyl-CoA, paromomycin
was totally inactivated by AAC(3)-VII (results not shown).
Paromomycin resistance and enzyme activities. To examine
more closely the implications of the PPH and AAC(3)-VII
activities in the paromomycin resistance phenotype of S.
rimosus, we constructed a number of plasmids carrying the
genes for these two enzymes. Cloning and expression of
these genes in S. lividans have been reported elsewhere (14,
18). To diminish gene dosage interferences, the genes pph
(encoding PPH) and aacC7 [encoding AAC(3)-VII] were
inserted in the low-copy-number plasmid pIJ41 (20) (Fig. 1).
The direction of transcription of pph is not yet known.
Therefore, to examine any possible influence from plasmid
promoter(s), plasmids pMA1.2 and pMA2.1, containing the
TABLE 2. Paromomycin resistance and PPH and AAC activities
of several Stireptomvces strains
Sp act (mU/mg Paromomycin
Organism Plasmid of protein) resistance
AAC PPH (~Lg/ml)6
S. lividans 1326 0.008 0 <2
S. rimosus f. paro- 0.200 31.00 3,000
momycinus
S. lividans
MA1.2 pMA1.2 0.010 26.95 60
MA2.1 pMA2.1 0.012 25.70 50
MA4.2 pMA4.2 2.300 0 120
MA4221 pMA4221 1.893 38.78 1,000
" Determined as described in Materials and Methods; 1 mU is equivalent to
1 nmol of acetylated or phosphorylated paromomycin produced per min.b Determined by the ability of the clones to grow in minimal agar plates
containing the indicated concentrations of paromomycin (7).
inserted DNA in the two possible orientations, were con-
structed (Fig. 1). S. lividans transformants harboring either
pMA1.2 or pMA2.1 expressed similar amounts of PPH
activity (Table 2), which suggests that expression of the pph
gene in both clones is not affected by foreign sequences. The
values for PPH activity in cell extracts from these transfor-
mants and from S. rimosus were similar. However, the
paromomycin resistance levels in the transformants were
about 30-fold lower than in the producing organism (Table
2). A similar situation was found in S. lividans MA4.2, a
transformant harboring aacC7 in a pIJ41-derived plasmid
(pMA4.2) (Table 2 and Fig. 1). In this plasmid, the DNA
fragment containing aacC7, whose direction of transcription
is known (14), replaced most of the neo gene, including its
promoter (1, 23). Although any effect of a plasmid promoter
could not be discounted, such an effect would not modify the
interpretation of the results described below. Thus, clone S.
lividans MA4.2 contained about 11-fold-higher levels of
AAC(3)-VII activity than did S. rimosus; however, its paro-
momycin resistance was 25-fold lower than that of the
parental strain (Table 2). Therefore, it is clear that neither
pph nor aacC7 per se can determine the high levels of
resistance found in S. rimosus (Table 2). When both genes
were included in the same construction (plasmid pMA4221;
Fig. 2), the relevant S. lividans transformant had a high level
of paromomycin resistance, which still was threefold lower
than that in S. rimosus (Table 2). Note that the levels of
enzyme activities in the S. lividans clone containing both
aacC7 and pph (MA4221) were similar to those in the S.
lividans clones MA2.1 and MA4.2, which harbor a single
gene (Table 2). Thompson et al. (24) also reported that S.
lividans clones harboring a single aph or aac gene had only
low levels of resistance to neomycin, but clones carrying
both genes displayed high resistance levels which were
similar to those of S. fradiae, the producing organism.
A possible explanation for these findings is that either
phosphorylparomomycin or acetylparomomycin is a better
substrate for AAC(3)-VII or PPH, respectively, than is
unmodified paromomycin. Acetylparomomycin was a
poorer substrate for PPH than was the intact antibiotic (Fig.
2A), but phosphorylparomomycin was a better substrate for
AAC(3)-VII than was paromomycin (Fig. 2B). As suggested
by others, the doubly modified drug might block the antibi-
otic uptake mechanism more efficiently than does the singly
modified one (24). An increased modification rate of phos-
phorylparomomycin by AAC(3)-VII could facilitate this pro-
tective effect against the extracellular drug.
J BACTERIOL .
PAROMOMYCIN RESISTANCE IN S. RIMOSUS 333
5
4
n
-3
I
CLA l
cn
L.)
5 10 15 20 25 30
DRUG CONC. (pM)
1 2 3 4 5 6 7 8 9 10
DRUG CONC. ({M)
FIG. 2. Single and double modification of paromomycin. (A)
Phosphorylation of paromomycin and acetylparomomycin. Paro-
momycin (15 nmol) was fully acetylated with an S100 fraction (150
p.g of protein) from clone S. lividans MA4.2. Similarly, 15 nmol of
paromomycin was incubated with an S100 fraction (150 p.g of
protein) from S. lividans 1326. Samples of acetylparomomycin (0)
and paromomycin (0) were then used to perform the phosphoryla-
tion reaction, using an S100 fraction from S. lividans MA1.2 (30 ,ug
of protein per 50 RI of reaction mixture). To measure initial rates of
phosphorylation, reactions took place at 30° C for only 4 min. (B)
Acetylation of paromomycin and phosphorylparomomycin. The
indicated amounts of paromomycin (0) and purified phosphorylpa-
romomycin (0) (see Materials and Methods) were acetylated in
reaction mixtures (50 RI) containing an S100 fraction from S.
lividans MA4.2 (90 Rxg of protein per incubation). Incubations took
place at 30° C for 15 min.
The different rates of acetylation of intact paromomycin
and phosphorylparomomycin allow us to speculate that if
these modifications take place on intermediates of the bio-
synthetic pathway, the resulting molecules could be better
substrates for the successive enzymatic step(s). In this
respect, it has been shown that N-acetyl-O-demethylpu-
romycin is used more actively by the O-demethylpuromycin
O-methyltransferase than is O-demethylpuromycin (24).
A number of aminocyclitol-producing actinomycetes con-
tain ribosomes that are resistant to the relevant antibiotics.
S. lividans transformants harboring the genes for ribosomal
resistance display similar levels of resistance to the produc-
ing organisms, which suggests that in the latter no other form
of self-protection against aminocyclitols is required (22).
However, S. kanamyceticus and S. tenebrarius also contain
antibiotic-inactivating enzymes (16, 27). Although the reason
for the coexistence of several resistance processes is not
clear, ribosomal resistance to the final antibiotic molecule
may not prevent the toxicity of certain precursors; such
toxic intermediates could be inactivated by the modifying
enzymes.
Whether S. rimosus contains resistance-conferring genes
other than the two described here remains an open question.
The streptomycin producer S. griseus has recently been
shown to have two different APH activities, which modify
either the 3"- or 6-hydroxyl groups of streptomycin (6). Also,
Streptoverticillum eurocidicus (M. D. Abarca and A.
Jimenez, unpublished observations) and S. tenebrarius (E.
Cundliffe, personal communication) contain the genes for
two different destomycin PPHs and two different nebramy-
cin AACs, respectively.
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